NR5A1 and neoplasm: To elucidate the underlying mechanisms driving the antitumor effects of EL and ELP, we used a CT26 tumor-bearing mice model to study the effects on the tumor immune microenvironment by intratumorally injecting PTX, EL, and ELP (Figure 6).